Skip to main content
. 2020 Jul 28;4(14):3416–3426. doi: 10.1182/bloodadvances.2020002253

Table 1.

IVIG products included in this study

IVIG preparation Included in cohort description Included in laboratory studies Formulation Concentration, w/v
Product I Yes (2006-2007) No (not available) Lyophilized 5% upon reconstitution
Product II Yes (2007-2013) Yes Liquid 9%-11%
Product III Yes (2007-2013) Yes Liquid 9%-11%
Product IV Yes (2007-2013) Yes Liquid 10%
Product V No Yes Liquid 5%
Product VI No (rescue product) Sparingly (limited supplies) Lyophilized 5% or 10% upon reconstitution

w/v, weight-to-volume ratio (%).